Drugs

Sep 01, 2015 at 20:48 | Source: Moneycontrol.com
Trimurthi Drugs & Pharmaceuticals at its meeting held on September 01, 2015, has considered the resignation of Mr. Arvind Kumar Bhangadia from the position of Managing director. However the board has accepted the resignation and requested him to continue till the appointment of new Managing director.
Sep 01, 2015 at 10:01 | Source: Moneycontrol.com
"Sun Pharma today begins the integration of its Opiates business in Australia following the successful completion of this acquisition from GSK (announced in March 2015)," said the country's largest drug maker in its filing.
Aug 31, 2015 at 11:04 | Source: Moneycontrol.com
Broking house Angel Broking has maintained accumulate rating on the stock with a target of Rs 872.
Aug 31, 2015 at 09:39 | Source: Moneycontrol.com
Aurobindo Pharma has received the final approval from the US Food & Drug Administration (USFDA) to manufacture and market Raloxifene Hydrochloride Tablets USP 60mg (ANDA 204310).
Aug 30, 2015 at 13:53 | Source: PTI
According to a notification issued by the US Food and Drug Administration, Sun Pharma's recall was initiated last month under Class-III classification which was as 'a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences'.
Aug 29, 2015 at 15:46 | Source: PTI
The approval by the US FDA for Raloxifene Hydrochloride tablets is for strength of 60 mg, which is bio and therapeutically equivalent to the reference listed drug product (RLD) Evista, 60 mg of Eli Lilly, the company said in a statement.
Aug 28, 2015 at 12:57 | Source: PTI
The shares opened on a bullish note at Rs 673.25 and jumped 2.81 percent to an early high of Rs 679.75
Aug 27, 2015 at 20:53 | Source: PTI
Cipla is having presence in over 150 countries, manufacture drugs in over 50 dosages and has a portfolio in excess of 1,500 products.
Aug 27, 2015 at 18:01 | Source: PTI
The company has received final approval for its Omeprazole delayed-release capsules (40 mg) from the United States Food and Drugs Administration (USFDA), Lupin Ltd said in a statement.
Aug 27, 2015 at 13:39 | Source: PTI
The company has received final approval from the US Food and Drug Administration (USFDA) to manufacture and market Entecavir tablets in strengths of 0.5mg and 1mg, Aurobindo Pharma said in a statement.
Messages on Drugs »

maximindia

Platinum Member

678 Followers

Ranbaxy Labs  

If one notice everyday USA approving many indian co`s formulation in many blockbuster drugs and naturally RBaxy and SUN is in t top of lists.Reasoning is not far to see that USA want Modi`s visit of USA become highflier and what make SUN/RBaxy combo approvals as forerunners as SUN is based

4.53 PM Jul 8th 2014

Market Statistician

Platinum Member

14174 Followers

Mangalam Drugs  

Mangalam Drugs & Organics has touched a 52-week high of Rs 10.25. At 15:13 hrs, the share was quoting at Rs 10.19, up Rs 0.27, or 2.72%. See more

3.15 PM Jul 8th 2014

Market Statistician

Platinum Member

14174 Followers

Aarey Drugs  

At 15:13 hrs, Aarey Drugs and Pharmaceuticals was trading at Rs 21.40 up 7.65%, with a huge increase in its volume of shares traded. Till now over 367,096 shares were traded as compared to its 5-day average of 114,854 shares.

3.15 PM Jul 8th 2014

Market Statistician

Platinum Member

14174 Followers

Parenteral Drug  

At 15:14 hrs, Parenteral Drugs (India) was trading at Rs 33.80 up 4.32%, with a huge increase in its volume of shares traded. Till now over 448,621 shares were traded as compared to its 5-day average of 90,823 shares.

3.15 PM Jul 8th 2014

Market Statistician

Platinum Member

14174 Followers

Mangalam Drugs  

Mangalam Drugs & Organics has touched a 52-week high of Rs 10.21. At 14:14 hrs, the share was quoting at Rs 10.25, up Rs 0.33, or 3.33%. See more

2.15 PM Jul 8th 2014

Market Statistician

Platinum Member

14174 Followers

Aarey Drugs  

At 14:12 hrs, Aarey Drugs and Pharmaceuticals was trading at Rs 20.94 up 5.33%, with a huge increase in its volume of shares traded. Till now over 304,764 shares were traded as compared to its 5-day average of 114,854 shares.

2.15 PM Jul 8th 2014

Market Statistician

Platinum Member

14174 Followers

Parenteral Drug  

At 14:13 hrs, Parenteral Drugs (India) was trading at Rs 35.20 up 8.64%, with a huge increase in its volume of shares traded. Till now over 392,958 shares were traded as compared to its 5-day average of 90,823 shares.

2.15 PM Jul 8th 2014

madrasan

Silver Member

1 Followers

Shasun Pharma  

The company might be a beneficiary of the Sevelamer molecule drugs going off patent in the US. Shasun is expected to be one of the Active Pharmaceutical Ingredients (API) supplier of these drugs. The latest indication of these drugs going off patent is that one of the molecules Sevelamer Carbonate

12.48 PM Jul 8th 2014

Market Statistician

Platinum Member

14174 Followers

Aarey Drugs  

At 12:14 hrs, Aarey Drugs and Pharmaceuticals was trading at Rs 20.83 up 4.78%, with a huge increase in its volume of shares traded. Till now over 256,745 shares were traded as compared to its 5-day average of 114,854 shares.

12.15 PM Jul 8th 2014

Market Statistician

Platinum Member

14174 Followers

Parenteral Drug  

At 12:14 hrs, Parenteral Drugs (India) was trading at Rs 36.50 up 12.65%, with a huge increase in its volume of shares traded. Till now over 275,045 shares were traded as compared to its 5-day average of 90,823 shares.

12.15 PM Jul 8th 2014

Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.